{"gene":"HEY2","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2004,"finding":"Hey1 and Hey2 are essential downstream transducers of Notch signaling in cardiovascular development; combined loss of Hey1 and Hey2 in mice causes embryonic lethality with global failure of vascular remodeling, and remaining arteries fail to express arterial endothelial markers CD44, neuropilin1, and ephrin-B2, establishing Hey1/Hey2 as mediators of arterial cell fate decision downstream of Notch1/Jagged1 signaling.","method":"Mouse knockout (Hey1-/-, Hey2-/-, Hey1/Hey2 double KO), genetic epistasis with Notch1 and Jagged1 knockouts, in situ hybridization for arterial markers","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined vascular phenotype, replicated across multiple genotypes and epistasis experiments","pmids":["15107403"],"is_preprint":false},{"year":2002,"finding":"Hey2 (gridlock ortholog) is required for cardiac morphogenesis; targeted disruption in mice produces ventricular septal defects, tetralogy of Fallot, and tricuspid atresia, establishing Hey2 as an important regulator of cardiac septation and morphogenesis downstream of the Notch/JAG1 pathway.","method":"Gene targeting (mouse knockout), histological and morphological analysis","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 — clean KO with well-defined cardiac phenotype, independently confirmed by multiple labs","pmids":["12372254","12454287","12372253"],"is_preprint":false},{"year":2002,"finding":"Loss of Hey2 (CHF1) in mice causes ventricular septal defects and cardiomyopathy, with surviving adult animals developing impaired myocardial contractility, demonstrating CHF1/Hey2 plays a role in regulation of ventricular septation and normal myocardial function.","method":"Targeted gene disruption (mouse KO), histology, echocardiography, survival analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cardiac phenotype replicated across multiple labs","pmids":["12454287"],"is_preprint":false},{"year":2003,"finding":"SIRT1 physically associates with HEY2 (and HES1) both in vitro and in vivo, and both SIRT1-dependent and SIRT1-independent deacetylase pathways are involved in HEY2-mediated transcriptional repression, demonstrating that the bHLH repressor–Sir2 interaction is conserved from Drosophila to humans.","method":"Co-immunoprecipitation (in vitro and in vivo), reporter/transfection assays with deacetylase inhibitors","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2/3 — reciprocal Co-IP plus functional reporter assay, single lab","pmids":["12535671"],"is_preprint":false},{"year":2003,"finding":"Misexpression of Hesr2/Hey2 in mouse brain transiently maintains neural precursor cells, inhibits transcription induced by neuronal bHLH genes Mash1 and Math3 (in transfection assay), and promotes maintenance of neural progenitors, thereby increasing late-born neurons and subsequently astroglial cells.","method":"In utero electroporation (misexpression), transient transfection reporter assays, in situ hybridization","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function in vivo with defined cellular phenotype plus in vitro mechanistic assay","pmids":["12947105"],"is_preprint":false},{"year":2001,"finding":"HERP1/HEY2 is a direct primary target gene of Notch signaling in A10 smooth muscle cells: Notch intracellular domain (NICD) activates the HERP1 promoter in an RBP-Jκ-dependent manner, induces endogenous HERP1 mRNA and protein even without de novo protein synthesis, and RBP-Jκ is required for induction.","method":"Promoter-reporter assays, co-culture with Notch ligand-expressing cells, cycloheximide treatment, RBP-Jκ-deficient cell rescue experiments, RT-PCR","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1/2 — multiple orthogonal methods (promoter assay, endogenous mRNA induction, cycloheximide, genetic rescue) in a single study","pmids":["11741889"],"is_preprint":false},{"year":2005,"finding":"HERP1/HEY2 inhibits myocardin-induced vascular smooth muscle cell differentiation by physically interacting with SRF and interfering with SRF binding to CArG-box elements in SMC marker gene promoters.","method":"Co-immunoprecipitation, EMSA (electrophoretic mobility shift assay), reporter assays, overexpression in 10T1/2 cells, immunohistochemistry","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 1/2 — direct protein interaction (Co-IP), DNA-binding interference (EMSA), and functional reporter assay in same study","pmids":["16151017"],"is_preprint":false},{"year":2004,"finding":"CHF1/Hey2 deficiency in mice reduces neointima formation after arterial wire injury and impairs VSMC proliferation and PDGF/HB-EGF-induced migration, correlating with decreased Rac1 GTPase activation and reduced levels of the Rac GEF Sos1.","method":"Mouse KO, wire injury model, in vitro VSMC migration/proliferation assays, Rac1 activation assay, western blot for Sos1","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 — KO with defined in vivo and in vitro phenotypes plus molecular pathway dissection","pmids":["15345511"],"is_preprint":false},{"year":2005,"finding":"Hey1/Hey2 proteins directly homo- and heterodimerize with each other and with other hairy-related bHLH proteins (c-hairy1), as shown by in vitro and in vivo interaction assays, suggesting combinatorial action in the segmentation clock and somite patterning.","method":"In vitro and in vivo interaction assays (co-immunoprecipitation/pull-down), in situ hybridization in Dll1 and Notch1 knockout mice","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2/3 — direct protein interaction assays, single study","pmids":["11076679"],"is_preprint":false},{"year":2006,"finding":"CHF1/Hey2 overexpression in transgenic mouse myocardium suppresses phenylephrine-induced cardiac hypertrophy; mechanistically, CHF1/Hey2 directly binds GATA4 (by co-immunoprecipitation), inhibits GATA4 binding to its recognition sequence in the ANF promoter, and suppresses GATA4-dependent induction of hypertrophy marker genes (ANF, BNP, β-MHC).","method":"Transgenic mouse overexpression, isolated neonatal myocyte assays, co-immunoprecipitation, reporter assays with GATA4","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 1/2 — direct protein interaction (Co-IP), DNA-binding inhibition, in vivo and in vitro functional phenotype converge","pmids":["16603706"],"is_preprint":false},{"year":2005,"finding":"CHF1/Hey2 suppresses GATA-6-dependent smooth-muscle myosin heavy chain (SM-MHC) promoter activity through direct physical interaction with GATA-6 (co-immunoprecipitation); the bHLH domain of CHF1/Hey2 is required for this transcriptional repression.","method":"Co-immunoprecipitation, cotransfection reporter assays, bHLH domain mutational analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — direct protein interaction plus mutational dissection, single lab","pmids":["16293227"],"is_preprint":false},{"year":2008,"finding":"Foxc2 directly activates the Hey2 promoter via conserved Foxc binding elements; Foxc2 physically and functionally interacts with the Notch transcriptional activation complex (Su(H)/NICD) to induce Hey2 promoter activity; VEGF-activated PI3K and ERK pathways modulate Foxc transcriptional activity in Hey2 induction.","method":"Promoter-reporter assays, co-immunoprecipitation, chromatin immunoprecipitation (ChIP), EMSA, endothelial cell transfection","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1/2 — multiple orthogonal methods (ChIP, Co-IP, EMSA, reporter) in single study","pmids":["18545664"],"is_preprint":false},{"year":2006,"finding":"Hypoxia induces Dll4 and Hey2 expression via HIF-1α; Hey2 in endothelial progenitor cells represses COUP-TFII (venous identity regulator), promoting arterial cell fate; Hey factors in turn repress HIF-1α-induced gene expression, creating a negative feedback loop in the Dll4-Notch-Hey2 signaling cascade.","method":"Hypoxia treatment of cell lines, promoter analysis (HIF-1α binding sites), co-culture/overexpression experiments, quantitative RT-PCR","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2/3 — promoter analysis plus functional overexpression, single lab","pmids":["17045587"],"is_preprint":false},{"year":2007,"finding":"Forced expression of Hesr2/Hey2 throughout the cardiac lineage in mice suppresses Tbx2 and Bmp2 expression and eliminates the atrioventricular (AV) canal, demonstrating that Hey2 directly suppresses Tbx2 to regulate AV boundary formation; this regulation is independent of Notch2 signaling.","method":"Myocardial misexpression transgenic mice, in situ hybridization, genetic epistasis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — defined loss/gain-of-function cardiac phenotype with molecular target identification, epistasis with Notch2","pmids":["17259303"],"is_preprint":false},{"year":2005,"finding":"Combined knockout of Hesr1 and Hesr2/Hey2 in mice is embryonic lethal at E11.5 and recapitulates most cardiovascular phenotypes of disrupted Notch pathway mutants (arterial-venous specification defects, septation, cushion formation), demonstrating functional redundancy between Hey1 and Hey2 as downstream effectors of Notch signaling in cardiovascular development.","method":"Mouse double knockout, in situ hybridization, histological analysis, genetic epistasis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — clean double KO with defined cardiovascular phenotype, epistasis with Notch pathway","pmids":["15680351"],"is_preprint":false},{"year":2009,"finding":"Hey2 expression in cochlear pillar cells is maintained by FGF signaling independently of Notch; Hey2 blocks hair cell differentiation, and mutation of Hey2 makes pillar cells sensitive to loss of Notch signaling allowing them to differentiate as hair cells, placing Hey2 downstream of FGF but independent of Notch in pillar cell fate maintenance.","method":"Mouse knockout, Notch inhibitor treatment, FGF treatment, cochlear explant cultures, cell fate tracing","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 — KO with defined cellular phenotype, pharmacological Notch inhibition, FGF stimulation, multiple methods","pmids":["19154718"],"is_preprint":false},{"year":2010,"finding":"TAp73 promotes long-term neural stem cell maintenance by transcriptionally regulating Hey2; Hey2 downstream of TAp73 prevents premature differentiation of neural precursors, establishing a TAp73→Hey2 transcriptional axis in adult neurogenesis.","method":"Mouse KO (TAp73), neural stem cell isolation, overexpression/knockdown of Hey2, BrdU incorporation, differentiation assays","journal":"Current biology : CB","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with defined cellular phenotype, Hey2 as direct transcriptional target validated by rescue experiments","pmids":["21074438"],"is_preprint":false},{"year":2010,"finding":"In zebrafish, Hey2 is required upstream of Notch for hematopoietic stem cell (HSC) formation in the dorsal aorta; Hey2 expression is induced downstream of cloche/Scl and maintained by Hedgehog and VEGF signaling; knockdown of Hey2 reduces Notch receptor expression in aortic angioblasts, and Notch activation rescues HSC formation in hey2 morphants.","method":"Zebrafish morpholino knockdown, Notch activation (genetic rescue), in situ hybridization, epistasis analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — morpholino KD with defined HSC phenotype, genetic epistasis placing Hey2 upstream of Notch","pmids":["20511544"],"is_preprint":false},{"year":2011,"finding":"CHF1/Hey2 regulates MMP10 expression through multiple E-box elements in the MMP10 promoter; loss/knockdown of CHF1/Hey2 increases MMP10 expression and activity in VSMCs; mutation of E-boxes abolishes repression and unmasks an activator function for CHF1/Hey2.","method":"KO/siRNA knockdown, promoter-reporter assays, E-box mutagenesis, MMP10 activity assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assays with site-directed mutagenesis plus endogenous gene expression analysis","pmids":["22079635"],"is_preprint":false},{"year":2012,"finding":"Conditional myocardial knockout of CHF1/Hey2 causes abnormalities in calcium handling after pressure overload, mediated by increased FKBP12.6 expression; treatment with FK506 (which inhibits FKBP12.6 association with ryanodine receptor) restored contractile function in KO cardiomyocytes, linking CHF1/Hey2 to EC coupling via FKBP12.6.","method":"Conditional myocardial KO mice, aortic banding, isolated cardiomyocyte calcium transient measurements, FK506 pharmacological rescue, quantitative RT-PCR","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with defined functional phenotype plus pharmacological rescue identifying molecular mechanism","pmids":["22408025"],"is_preprint":false},{"year":2013,"finding":"Hey2 regulates bone remodeling: conditional osteoblast-specific Hey2 deletion increases trabecular bone volume and suppresses alkaline phosphatase (ALPL) activity; Hey2 transgenic overexpression in osteoblasts decreases osteoblast activity, increases bone resorption, and induces IL-6 (promoting osteoclastogenesis) in a sex-dependent manner.","method":"Conditional KO (Osx-Cre and Oc-Cre), transgenic overexpression, bone histomorphometry, ALPL activity assays, osteoclastogenesis co-culture assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO and transgenic OE with defined bone phenotype and molecular readout, single lab","pmids":["23782701"],"is_preprint":false},{"year":2013,"finding":"COUP-TFII directly binds the Hey2 promoter and downregulates Hey2 expression in arterial endothelial cells, as shown by ChIP, EMSA, and promoter analysis; Hey2 in turn regulates EphrinB2 expression downstream, placing Hey2 as part of the COUP-TFII→Hey2→EphrinB2 arteriovenous specification hierarchy.","method":"ChIP, EMSA, promoter analysis, lentiviral overexpression/shRNA knockdown in human endothelial cells, qRT-PCR","journal":"Basic research in cardiology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP + EMSA + functional promoter assay in human endothelial cells","pmids":["23744056"],"is_preprint":false},{"year":2014,"finding":"Conditional double knockout of Hey1 and Hey2 in prosensory cochlear cells causes premature upregulation of the pro-hair cell factor Atoh1 and premature hair cell differentiation, establishing Hey1/Hey2 as suppressors of Atoh1 in cochlear progenitor maintenance; this prosensory expression and its graded downregulation is controlled by Hedgehog signaling in a largely FGFR-dependent manner.","method":"Conditional double knockout (Hey1/Hey2), in situ hybridization, immunofluorescence, FGFR pharmacological inhibition","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — conditional double KO with defined molecular and cellular phenotype, pathway epistasis","pmids":["25232121"],"is_preprint":false},{"year":2014,"finding":"Myocardial-specific deletion of CHF1/Hey2 results in 50% reduction in cardiomyocyte action potential dV/dT, 50-75% reduction in SCN5A, KCNJ2, and CACNA1C ion channel subunit gene expression, increased delayed afterdepolarizations, and ~3-fold expansion of cardiac conduction system tissue, linking CHF1/Hey2 to transcriptional regulation of cardiac ion channel genes.","method":"Myocardial-specific conditional KO, patch clamp electrophysiology, qRT-PCR for ion channel gene expression, CCS-LacZ reporter cross","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1/2 — conditional KO with electrophysiological and molecular phenotypes, multiple orthogonal methods","pmids":["24687990"],"is_preprint":false},{"year":2015,"finding":"Serum/BMP9 induces Hey1 and Hey2 transcription in endothelial cells through Alk1 (BMP receptor) signaling independently of canonical Notch (gamma-secretase or dominant-negative MAML1 did not prevent induction), identifying BMP/Alk1 as a Notch-independent upstream activator of Hey2 in endothelial cells.","method":"Gamma-secretase inhibition, dominant-negative MAML1 expression, soluble Alk1/Alk3 receptor treatment, BMP9 stimulation, qRT-PCR","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological and genetic pathway inhibition with multiple controls, single lab","pmids":["25799559"],"is_preprint":false},{"year":2017,"finding":"HEY2 controls normal transmural electrophysiological gradient in the ventricle: Hey2+/- mice show reduced expression of Kcnip2 and Kcnd2 (Ito subunits) in subepicardium, diminished transmural Ito differences and J-wave amplitude; in humans, Brugada syndrome risk allele at rs9388451 associates with increased HEY2 expression, and HEY2 coexpression with KCNIP2 is the strongest genome-wide correlate, identifying a HEY2→KCNIP2 ion channel patterning axis.","method":"Heterozygous KO mice, patch-clamp electrophysiology (subepicardial vs. subendocardial cardiomyocytes), surface ECG, genome-wide coexpression analysis, eQTL analysis in human LV samples","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1/2 — KO electrophysiology, human eQTL, and genome-wide coexpression converge on same mechanism","pmids":["28637782"],"is_preprint":false},{"year":2017,"finding":"Hey2 overexpression is sufficient to induce endothelial-to-mesenchymal transition (EndoMT) in HUVECs; endothelial-specific conditional deletion of Hey2 in mice reduces EndoMT frequency and mitigates radiation-induced proctitis, demonstrating a causal role for Hey2 in driving EndoMT.","method":"siRNA knockdown and plasmid overexpression in HUVECs, Cre-LoxP endothelial-specific KO mice, irradiation model, immunocytochemistry, western blot, qPCR","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function and conditional KO with defined EndoMT phenotype in vitro and in vivo","pmids":["28694461"],"is_preprint":false},{"year":2018,"finding":"HEY2 is a key mediator of NKX2-5 function during human cardiomyogenesis: NKX2-5 deletion in hESCs impairs cardiomyogenesis and HEY2 expression; molecular profiling and genetic rescue experiments demonstrate HEY2 acts downstream of NKX2-5 in the cardiac transcriptional network to enable VCAM1 activation and PDGFRα downregulation.","method":"hESC gene deletion (NKX2-5 null), molecular profiling, genetic rescue (HEY2 overexpression), action potential recording, gene expression analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — human ESC KO plus genetic rescue with molecular profiling, multiple methods","pmids":["29636455"],"is_preprint":false},{"year":2018,"finding":"Notch signaling and Nrg1/ErbB2 regulate Hey2 expression level (but not pattern) in myocardium/endocardium; FGF signaling regulates Hey2 expression pattern in early myocardium and also regulates Hey2 level in a Notch1-dependent manner; Hey2 is expressed in endocardial cells of AV canal, outflow tract, and base of trabeculae in addition to compact myocardium.","method":"RNAscope in situ hybridization, Hey2-CreERT2 knockin lineage tracing, pathway disruption (Notch, FGF, Nrg1/ErbB2 inhibition/KO)","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — novel lineage tracing tool plus multiple pathway epistasis experiments, single lab","pmids":["29422515"],"is_preprint":false},{"year":2019,"finding":"HEY2 forms complexes with Smad3 and Smad4 and represses Smad3/Smad4 transcriptional activity, thereby inhibiting TGF-β-induced growth arrest and c-Myc downregulation in hepatocellular carcinoma cells; HEY2 overexpression suppresses TGF-β biological responses while HEY2 knockdown enhances them.","method":"Co-immunoprecipitation, siRNA knockdown and overexpression, reporter assays, western blot, qRT-PCR","journal":"American journal of translational research","confidence":"Medium","confidence_rationale":"Tier 2/3 — protein complex (Co-IP) plus functional gain/loss-of-function with defined pathway readout, single lab","pmids":["31396342"],"is_preprint":false},{"year":2020,"finding":"A distal Hey2 enhancer conserved in mouse and human drives ventricular free-wall myocyte-specific expression; this enhancer requires conserved T-box and Gata binding sites (not NK-2 sites), and Tbx20 is required for enhancer activity in embryonic ventricles; Tbx20 cooperates with cardiac GATA proteins to control the ventricular enhancer.","method":"Enhancer deletion in mice (CRISPR), in vivo reporter assays, site-directed mutagenesis of binding sites, Tbx20 null mice, luciferase reporter assays","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1/2 — in vivo enhancer deletion, mutational analysis, and epistasis with Tbx20 KO in single study","pmids":["32035085"],"is_preprint":false},{"year":2020,"finding":"Germline loss-of-function variants in HEY2 functional domains disrupt its repressive activity (shown by reporter gene assay) and cause congenital heart defects and thoracic aortic aneurysms in humans, with heterozygous carriers showing cardiovascular defects at high penetrance.","method":"Genome sequencing, gene-based association test (MetaSKAT), reporter/expression assays for variant functional consequences","journal":"Genetics in medicine","confidence":"Medium","confidence_rationale":"Tier 3 — human variant with functional reporter assay validation, single study","pmids":["32820247"],"is_preprint":false},{"year":2021,"finding":"Hey2 conditional KO in the right ventricle/outflow tract (Mef2c-AHF-Cre) causes right ventricular hypoplasia; RNA-seq reveals ectopic induction of Tbx2 in the RV chamber myocardium, leading to reduced Mycn expression and decreased S-phase cells, establishing a Hey2→Tbx2→Mycn pathway controlling RV cardiomyocyte proliferation.","method":"Conditional KO (Mef2c-AHF-Cre), RNA-seq, in situ hybridization, BrdU incorporation, histology","journal":"Development, growth & differentiation","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with unbiased transcriptomic pathway discovery and cellular proliferation readout","pmids":["33410138"],"is_preprint":false},{"year":2025,"finding":"HEY2 enriches at promoters of metabolic genes (Ppargc1/PGC-1α, Esrra, Cpt1) and colocalizes with HDAC1 to effectuate histone deacetylation and transcriptional repression of mitochondrial oxidation genes; HEY2-induced impairment of mitochondrial respiration causes elevated ROS and cardiomyocyte apoptosis; restoration of PPARGC1A/ESRRA rescues bioenergetic deficits, defining an HEY2/HDAC1–Ppargc1/Cpt1 transcriptional module controlling cardiac energy metabolism.","method":"Genome-wide ChIP-seq, ATAC-seq, Hi-C, CUT&RUN; conditional KO and overexpression in zebrafish and mouse; mitochondrial respiration assays; doxorubicin cardiac injury model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — multiple genome-wide chromatin assays, in vivo KO/OE, functional metabolic rescue, replicated across species","pmids":["39747914"],"is_preprint":false},{"year":2025,"finding":"A novel HEY2 missense variant (p.Glu57Asp) completely disrupts HEY2 repressive transcriptional activity in a reporter gene assay and segregates with non-syndromic Tetralogy of Fallot in a family, confirming that HEY2 repressor function is required for normal conotruncal cardiac development.","method":"Sanger sequencing, gene reporter assay (loss of repression), family segregation analysis","journal":"European journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 3 — single variant with functional reporter assay, single study","pmids":["40481234"],"is_preprint":false}],"current_model":"HEY2 is a bHLH transcriptional repressor that acts as a direct downstream target of Notch (and, independently, FGF/BMP/Alk1) signaling to regulate arterial cell fate, cardiac morphogenesis (ventricular septation, RV development, AV canal), and ion channel patterning (KCNIP2/Ito, SCN5A); it represses target genes by recruiting HDAC1 to promoters (including PGC-1α/CPT1 metabolic genes), and inhibits the activity of GATA4, GATA-6, SRF/myocardin, and Smad3/Smad4 complexes through direct protein–protein interactions, thereby suppressing pathological cardiac hypertrophy, vascular smooth muscle dedifferentiation, and mitochondrial metabolic reprogramming."},"narrative":{"teleology":[{"year":2001,"claim":"How Hey2 is activated was unknown; demonstration that Notch intracellular domain directly induces HEY2 transcription through RBP-Jκ-dependent promoter activation — even without de novo protein synthesis — established HEY2 as a primary transcriptional target of Notch signaling.","evidence":"Promoter-reporter assays, cycloheximide treatment, RBP-Jκ-deficient cell rescue in smooth muscle cells","pmids":["11741889"],"confidence":"High","gaps":["Whether other pathways independently activate Hey2 was not addressed","Chromatin-level regulation of the Hey2 locus not examined"]},{"year":2002,"claim":"The in vivo requirement of Hey2 was uncertain; targeted disruption in mice revealed ventricular septal defects, tetralogy of Fallot, tricuspid atresia, and adult cardiomyopathy, establishing Hey2 as essential for cardiac septation and myocardial function.","evidence":"Mouse knockout, histology, echocardiography across multiple independent labs","pmids":["12372254","12454287","12372253"],"confidence":"High","gaps":["Whether Hey2 acts cell-autonomously in cardiomyocytes versus other cardiac cell types was unresolved","Direct transcriptional targets in heart unknown"]},{"year":2003,"claim":"The mechanism of Hey2-mediated repression was unclear; discovery that SIRT1 physically associates with HEY2 and participates in its repressive activity revealed that deacetylase recruitment is a key component of Hey2 transcriptional repression.","evidence":"Co-immunoprecipitation (in vitro and in vivo), reporter assays with deacetylase inhibitors","pmids":["12535671"],"confidence":"Medium","gaps":["Relative contribution of SIRT1-dependent vs. SIRT1-independent deacetylation not quantified","No genome-wide target identification"]},{"year":2004,"claim":"Whether Hey genes mediate Notch-dependent arterial identity was unknown; combined Hey1/Hey2 knockout recapitulated Notch1/Jagged1 vascular phenotypes with loss of arterial markers (ephrin-B2, neuropilin1), establishing Hey1/Hey2 as essential Notch effectors for arterial-venous specification.","evidence":"Hey1/Hey2 double KO mice, genetic epistasis with Notch1 and Jagged1 knockouts, arterial marker in situ hybridization","pmids":["15107403"],"confidence":"High","gaps":["Whether Hey2 directly represses venous genes or activates arterial genes was not distinguished","Endothelial cell-autonomous requirement not tested with conditional KO"]},{"year":2005,"claim":"How Hey2 suppresses smooth muscle differentiation was mechanistically unclear; demonstration that HEY2 physically binds SRF and blocks SRF-CArG box interaction revealed a direct protein–protein interference mechanism inhibiting myocardin-induced VSMC gene activation.","evidence":"Co-immunoprecipitation, EMSA, reporter assays in 10T1/2 cells","pmids":["16151017"],"confidence":"High","gaps":["Whether this mechanism operates in vivo during vascular development was not shown","Which Hey2 domain mediates SRF interaction was not mapped"]},{"year":2006,"claim":"Whether Hey2 modulates cardiac hypertrophy was unknown; transgenic overexpression of Hey2 suppressed phenylephrine-induced hypertrophy by directly binding GATA4 and blocking its DNA binding at hypertrophy gene promoters (ANF, BNP, β-MHC).","evidence":"Transgenic mouse, neonatal myocyte assays, co-immunoprecipitation, reporter assays","pmids":["16603706"],"confidence":"High","gaps":["Whether endogenous Hey2 loss enhances hypertrophy in vivo was not tested","Interaction with other GATA family members (GATA-6) in hypertrophy context not explored in this study"]},{"year":2007,"claim":"How the AV canal boundary is established was poorly understood; forced Hey2 expression throughout the heart eliminated the AV canal by suppressing Tbx2 and Bmp2, defining Hey2 as a chamber-specific repressor of AV canal identity independent of Notch2.","evidence":"Transgenic misexpression mice, in situ hybridization, Notch2 epistasis","pmids":["17259303"],"confidence":"High","gaps":["Whether Hey2 directly binds the Tbx2 promoter was not shown","Whether Hey2 repression of Tbx2 is sufficient or requires cofactors was not addressed"]},{"year":2008,"claim":"The upstream transcription factor network controlling Hey2 in endothelial cells was incompletely mapped; Foxc2 was shown to directly bind the Hey2 promoter and cooperate with the Notch transcriptional complex to activate Hey2 expression, integrating VEGF-PI3K/ERK signaling into Hey2 regulation.","evidence":"ChIP, EMSA, promoter-reporter assays, co-immunoprecipitation in endothelial cells","pmids":["18545664"],"confidence":"High","gaps":["Whether Foxc2 is required for Hey2 expression in vivo was not tested","Relative contribution of Foxc2 versus RBP-Jκ at the endogenous locus unknown"]},{"year":2009,"claim":"Whether Hey2 functions independently of Notch was uncertain in non-vascular contexts; in the cochlea, FGF signaling maintains Hey2 expression in pillar cells independently of Notch, and Hey2 loss sensitizes these cells to Notch inhibition, revealing a Notch-independent FGF–Hey2 axis in auditory cell fate.","evidence":"Mouse knockout, cochlear explant cultures with Notch inhibitor and FGF treatment","pmids":["19154718"],"confidence":"High","gaps":["Whether FGF directly activates Hey2 transcription or acts through intermediary factors was not resolved","Whether other Hey family members compensate in cochlea was not fully explored"]},{"year":2014,"claim":"Hey2's role in cardiac electrophysiology was unknown; conditional myocardial deletion revealed 50–75% reduction in SCN5A, KCNJ2, and CACNA1C expression with reduced action potential upstroke velocity and conduction system expansion, establishing Hey2 as a transcriptional regulator of cardiac ion channel gene expression.","evidence":"Myocardial-specific conditional KO, patch clamp, qRT-PCR, CCS-LacZ reporter","pmids":["24687990"],"confidence":"High","gaps":["Whether Hey2 directly binds ion channel gene promoters was not shown","Whether ion channel phenotype contributes to arrhythmia susceptibility in humans was not tested"]},{"year":2017,"claim":"The mechanism behind transmural electrophysiological heterogeneity in the ventricle was unclear; Hey2 haploinsufficiency in mice reduced subepicardial KCNIP2/Ito expression, and human eQTL analysis linked the HEY2 Brugada syndrome risk locus to HEY2–KCNIP2 coexpression, identifying a HEY2→KCNIP2 axis controlling transmural Ito gradient and Brugada syndrome susceptibility.","evidence":"Hey2+/− mice, subepicardial/subendocardial patch clamp, human left ventricular eQTL, genome-wide coexpression analysis","pmids":["28637782"],"confidence":"High","gaps":["Whether HEY2 directly binds the KCNIP2 regulatory region was not demonstrated","Functional rescue of Brugada phenotype by KCNIP2 restoration not tested"]},{"year":2020,"claim":"Cis-regulatory logic controlling ventricular Hey2 expression was undefined; a conserved distal enhancer requiring T-box (Tbx20) and GATA binding sites — but not NK-2 sites — was identified, revealing Tbx20/GATA as upstream activators at the chromatin level.","evidence":"CRISPR enhancer deletion in mice, site-directed mutagenesis, Tbx20 null mice, in vivo reporter assays","pmids":["32035085"],"confidence":"High","gaps":["Whether additional enhancers control Hey2 expression in other cardiac compartments was not addressed","3D chromatin architecture at the Hey2 locus not characterized in this study"]},{"year":2020,"claim":"Whether HEY2 variants cause human congenital heart disease was unresolved; germline loss-of-function variants disrupting HEY2 repressor activity were identified in patients with congenital heart defects and thoracic aortic aneurysms, establishing HEY2 as a human disease gene.","evidence":"Genome sequencing, gene-based association (MetaSKAT), reporter assay for functional variant assessment","pmids":["32820247"],"confidence":"Medium","gaps":["Small cohort size limits genotype–phenotype correlation","No animal model rescue of specific human variants performed","Mechanism by which loss of HEY2 causes aortic aneurysm not addressed"]},{"year":2021,"claim":"How Hey2 controls right ventricular growth was mechanistically unknown; conditional RV-specific deletion showed ectopic Tbx2 induction leading to Mycn downregulation and reduced cardiomyocyte proliferation, defining a Hey2⊣Tbx2⊣Mycn pathway governing RV expansion.","evidence":"Mef2c-AHF-Cre conditional KO, RNA-seq, BrdU incorporation, in situ hybridization","pmids":["33410138"],"confidence":"High","gaps":["Whether Hey2 directly binds the Tbx2 locus or acts indirectly was not resolved","Whether the same pathway operates in left ventricle was not tested"]},{"year":2025,"claim":"The chromatin mechanism of Hey2-mediated metabolic gene repression was unknown; genome-wide ChIP-seq revealed HEY2 occupancy at PGC-1α, ESRRA, and CPT1 promoters with colocalized HDAC1, mediating histone deacetylation and repression of mitochondrial oxidation genes; this causes impaired respiration, elevated ROS, and cardiomyocyte apoptosis, rescued by PPARGC1A/ESRRA restoration.","evidence":"ChIP-seq, ATAC-seq, Hi-C, CUT&RUN, conditional KO and overexpression in zebrafish and mouse, mitochondrial respiration assays, doxorubicin injury model","pmids":["39747914"],"confidence":"High","gaps":["Whether HDAC1 recruitment is sufficient or whether SIRT1 also participates at metabolic gene loci was not tested","Whether metabolic reprogramming contributes to the cardiac phenotypes of Hey2 KO mice was not directly addressed"]},{"year":null,"claim":"Key unresolved questions include: whether HEY2 directly binds the promoters of Tbx2, KCNIP2, and SCN5A or acts through intermediary factors; the structural basis for HEY2 selectivity among its diverse protein partners (GATA4, SRF, Smad3); and whether HEY2 metabolic target repression contributes to congenital heart disease pathogenesis in humans.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of HEY2 or its complexes","Direct binding at Tbx2, KCNIP2, SCN5A loci not demonstrated by ChIP","Genotype–phenotype correlations in humans limited by small cohort sizes"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[5,6,9,10,13,18,23,25,29,33,34]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[18,33]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,9,33]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,5,11,14,17,24,28]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,2,13,14,22,27,30,32]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[5,6,9,10,18,25,33]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[33]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[33]}],"complexes":[],"partners":["GATA4","SRF","SIRT1","HDAC1","SMAD3","SMAD4","HEY1","GATA6"],"other_free_text":[]},"mechanistic_narrative":"HEY2 is a bHLH transcriptional repressor that serves as a central effector of Notch, FGF, BMP/Alk1, and Hedgehog signaling in cardiovascular development, neural progenitor maintenance, and cochlear cell fate determination. It represses target gene transcription by binding E-box elements and recruiting HDAC1 to promoters of metabolic genes (PGC-1α, CPT1) and ion channel genes (KCNIP2, SCN5A), and it antagonizes the transcriptional activities of GATA4, GATA-6, SRF/myocardin, and Smad3/Smad4 through direct protein–protein interactions, thereby suppressing cardiac hypertrophy, vascular smooth muscle dedifferentiation, and TGF-β signaling [PMID:16603706, PMID:16293227, PMID:39747914, PMID:31396342, PMID:28637782]. In the developing heart, Hey2 maintains ventricular chamber identity by suppressing Tbx2 to sustain cardiomyocyte proliferation and regulates atrioventricular canal boundary formation, ventricular septation, and conduction system patterning; its loss causes ventricular septal defects, tetralogy of Fallot, right ventricular hypoplasia, and cardiomyopathy [PMID:12454287, PMID:17259303, PMID:33410138, PMID:24687990]. Germline loss-of-function variants in HEY2 cause congenital heart defects including tetralogy of Fallot and thoracic aortic aneurysms in humans [PMID:32820247, PMID:40481234]."},"prefetch_data":{"uniprot":{"accession":"Q9UBP5","full_name":"Hairy/enhancer-of-split related with YRPW motif protein 2","aliases":["Cardiovascular helix-loop-helix factor 1","hCHF1","Class B basic helix-loop-helix protein 32","bHLHb32","HES-related repressor protein 2","Hairy and enhancer of split-related protein 2","HESR-2","Hairy-related transcription factor 2","HRT-2","hHRT2","Protein gridlock homolog"],"length_aa":337,"mass_kda":35.8,"function":"Downstream effector of Notch signaling which may be required for cardiovascular development. Transcriptional repressor which binds preferentially to the canonical E box sequence 5'-CACGTG-3'. Represses transcription by the cardiac transcriptional activators GATA4 and GATA6","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UBP5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HEY2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HEY2","total_profiled":1310},"omim":[{"mim_id":"617546","title":"HELT bHLH TRANSCRIPTION FACTOR; HELT","url":"https://www.omim.org/entry/617546"},{"mim_id":"617492","title":"OLFACTOMEDIN 2; OLFM2","url":"https://www.omim.org/entry/617492"},{"mim_id":"612760","title":"SNF-RELATED KINASE; SNRK","url":"https://www.omim.org/entry/612760"},{"mim_id":"609034","title":"HES-RELATED bHLH TRANSCRIPTION FACTOR WITH YRPW MOTIF-LIKE PROTEIN; HEYL","url":"https://www.omim.org/entry/609034"},{"mim_id":"608677","title":"MIB E3 UBIQUITIN PROTEIN LIGASE 1; MIB1","url":"https://www.omim.org/entry/608677"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nuclear bodies","reliability":"Approved"},{"location":"Aggresome","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"blood vessel","ntpm":70.9},{"tissue":"heart muscle","ntpm":29.1}],"url":"https://www.proteinatlas.org/search/HEY2"},"hgnc":{"alias_symbol":["bHLHb32","HERP1","HESR2"],"prev_symbol":[]},"alphafold":{"accession":"Q9UBP5","domains":[{"cath_id":"4.10.280.10","chopping":"43-112","consensus_level":"medium","plddt":90.4566,"start":43,"end":112},{"cath_id":"1.10.287","chopping":"113-173","consensus_level":"medium","plddt":92.308,"start":113,"end":173}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBP5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBP5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBP5-F1-predicted_aligned_error_v6.png","plddt_mean":64.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HEY2","jax_strain_url":"https://www.jax.org/strain/search?query=HEY2"},"sequence":{"accession":"Q9UBP5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UBP5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UBP5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBP5"}},"corpus_meta":[{"pmid":"15107403","id":"PMC_15107403","title":"The Notch target genes Hey1 and Hey2 are required for embryonic vascular development.","date":"2004","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/15107403","citation_count":538,"is_preprint":false},{"pmid":"23872634","id":"PMC_23872634","title":"Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23872634","citation_count":418,"is_preprint":false},{"pmid":"19154718","id":"PMC_19154718","title":"Hey2 regulation by FGF provides a Notch-independent mechanism for maintaining pillar cell fate in the organ of Corti.","date":"2009","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/19154718","citation_count":213,"is_preprint":false},{"pmid":"17045587","id":"PMC_17045587","title":"Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.","date":"2006","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/17045587","citation_count":177,"is_preprint":false},{"pmid":"12372254","id":"PMC_12372254","title":"Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/12372254","citation_count":159,"is_preprint":false},{"pmid":"15680351","id":"PMC_15680351","title":"Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15680351","citation_count":150,"is_preprint":false},{"pmid":"12454287","id":"PMC_12454287","title":"Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12454287","citation_count":145,"is_preprint":false},{"pmid":"18545664","id":"PMC_18545664","title":"Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18545664","citation_count":142,"is_preprint":false},{"pmid":"12947105","id":"PMC_12947105","title":"The basic helix-loop-helix genes Hesr1/Hey1 and Hesr2/Hey2 regulate maintenance of neural precursor cells in the brain.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12947105","citation_count":137,"is_preprint":false},{"pmid":"11076679","id":"PMC_11076679","title":"Oscillating expression of c-Hey2 in the presomitic mesoderm suggests that the segmentation clock may use combinatorial signaling through multiple interacting bHLH factors.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11076679","citation_count":136,"is_preprint":false},{"pmid":"17611704","id":"PMC_17611704","title":"Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.","date":"2007","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17611704","citation_count":132,"is_preprint":false},{"pmid":"12372253","id":"PMC_12372253","title":"Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2 -/- mice.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/12372253","citation_count":129,"is_preprint":false},{"pmid":"12535671","id":"PMC_12535671","title":"Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12535671","citation_count":122,"is_preprint":false},{"pmid":"17259303","id":"PMC_17259303","title":"Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17259303","citation_count":103,"is_preprint":false},{"pmid":"16151017","id":"PMC_16151017","title":"HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box.","date":"2005","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16151017","citation_count":89,"is_preprint":false},{"pmid":"29636455","id":"PMC_29636455","title":"NKX2-5 regulates human cardiomyogenesis via a HEY2 dependent transcriptional network.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29636455","citation_count":89,"is_preprint":false},{"pmid":"11741889","id":"PMC_11741889","title":"HERP1 is a cell type-specific primary target of Notch.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11741889","citation_count":87,"is_preprint":false},{"pmid":"15345511","id":"PMC_15345511","title":"Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.","date":"2004","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15345511","citation_count":86,"is_preprint":false},{"pmid":"15297376","id":"PMC_15297376","title":"Targeted disruption of hesr2 results in atrioventricular valve anomalies that lead to heart dysfunction.","date":"2004","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/15297376","citation_count":85,"is_preprint":false},{"pmid":"18291358","id":"PMC_18291358","title":"Hesr1 and Hesr2 may act as early effectors of Notch signaling in the developing cochlea.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18291358","citation_count":84,"is_preprint":false},{"pmid":"11160397","id":"PMC_11160397","title":"The basic helix-loop-helix gene hesr2 promotes gliogenesis in mouse retina.","date":"2001","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11160397","citation_count":79,"is_preprint":false},{"pmid":"21074438","id":"PMC_21074438","title":"TAp73 acts via the bHLH Hey2 to promote long-term maintenance of neural precursors.","date":"2010","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/21074438","citation_count":72,"is_preprint":false},{"pmid":"10860664","id":"PMC_10860664","title":"Characterization of the human and mouse HEY1, HEY2, and HEYL genes: cloning, mapping, and mutation screening of a new bHLH gene family.","date":"2000","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10860664","citation_count":69,"is_preprint":false},{"pmid":"30365070","id":"PMC_30365070","title":"MicroRNA-98 reduces amyloid β-protein production and improves oxidative stress and mitochondrial dysfunction through the Notch signaling pathway via HEY2 in Alzheimer's disease mice.","date":"2018","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30365070","citation_count":64,"is_preprint":false},{"pmid":"18302773","id":"PMC_18302773","title":"Hey2 functions in parallel with Hes1 and Hes5 for mammalian auditory sensory organ development.","date":"2008","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18302773","citation_count":58,"is_preprint":false},{"pmid":"28637782","id":"PMC_28637782","title":"The Brugada Syndrome Susceptibility Gene HEY2 Modulates Cardiac Transmural Ion Channel Patterning and Electrical Heterogeneity.","date":"2017","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/28637782","citation_count":56,"is_preprint":false},{"pmid":"25232121","id":"PMC_25232121","title":"Hey1 and Hey2 control the spatial and temporal pattern of mammalian auditory hair cell differentiation downstream of Hedgehog signaling.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25232121","citation_count":49,"is_preprint":false},{"pmid":"16603706","id":"PMC_16603706","title":"Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.","date":"2006","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16603706","citation_count":48,"is_preprint":false},{"pmid":"25834021","id":"PMC_25834021","title":"Sox7 controls arterial specification in conjunction with hey2 and efnb2 function.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25834021","citation_count":44,"is_preprint":false},{"pmid":"20511544","id":"PMC_20511544","title":"Hey2 acts upstream of Notch in hematopoietic stem cell specification in zebrafish embryos.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20511544","citation_count":41,"is_preprint":false},{"pmid":"31565805","id":"PMC_31565805","title":"microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31565805","citation_count":35,"is_preprint":false},{"pmid":"25799559","id":"PMC_25799559","title":"Serum induces transcription of Hey1 and Hey2 genes by Alk1 but not Notch signaling in endothelial cells.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25799559","citation_count":34,"is_preprint":false},{"pmid":"30257372","id":"PMC_30257372","title":"LncRNA PRNCR1 interacts with HEY2 to abolish miR-448-mediated growth inhibition in non-small cell lung cancer.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30257372","citation_count":34,"is_preprint":false},{"pmid":"15389319","id":"PMC_15389319","title":"Phenotypic variability in Hey2 -/- mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome.","date":"2004","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/15389319","citation_count":30,"is_preprint":false},{"pmid":"29422515","id":"PMC_29422515","title":"Notch signaling regulates Hey2 expression in a spatiotemporal dependent manner during cardiac morphogenesis and trabecular specification.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29422515","citation_count":29,"is_preprint":false},{"pmid":"30355727","id":"PMC_30355727","title":"Hey2 regulates the size of the cardiac progenitor pool during vertebrate heart development.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30355727","citation_count":27,"is_preprint":false},{"pmid":"27191260","id":"PMC_27191260","title":"HEY2, a target of miR-137, indicates poor outcomes and promotes cell proliferation and migration in hepatocellular carcinoma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27191260","citation_count":24,"is_preprint":false},{"pmid":"28694461","id":"PMC_28694461","title":"Endothelial Hey2 deletion reduces endothelial-to-mesenchymal transition and mitigates radiation proctitis in mice.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28694461","citation_count":23,"is_preprint":false},{"pmid":"20382855","id":"PMC_20382855","title":"The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload.","date":"2010","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20382855","citation_count":22,"is_preprint":false},{"pmid":"39747914","id":"PMC_39747914","title":"The transcriptional repressor HEY2 regulates mitochondrial oxidative respiration to maintain cardiac homeostasis.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39747914","citation_count":19,"is_preprint":false},{"pmid":"30125982","id":"PMC_30125982","title":"microRNA-146a and Hey2 form a mutual negative feedback loop to regulate the inflammatory response in chronic apical periodontitis.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30125982","citation_count":19,"is_preprint":false},{"pmid":"24687990","id":"PMC_24687990","title":"Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24687990","citation_count":19,"is_preprint":false},{"pmid":"16293227","id":"PMC_16293227","title":"CHF1/Hey2 suppresses SM-MHC promoter activity through an interaction with GATA-6.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16293227","citation_count":17,"is_preprint":false},{"pmid":"31255287","id":"PMC_31255287","title":"Attenuation of PRRX2 and HEY2 enables efficient conversion of adult human skin fibroblasts to neurons.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31255287","citation_count":16,"is_preprint":false},{"pmid":"35802997","id":"PMC_35802997","title":"Berberine inhibited the formation of metastasis by intervening the secondary homing of colorectal cancer cells in the blood circulation to the lung and liver through HEY2.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35802997","citation_count":16,"is_preprint":false},{"pmid":"23744056","id":"PMC_23744056","title":"Impact of Hey2 and COUP-TFII on genes involved in arteriovenous differentiation in primary human arterial and venous endothelial cells.","date":"2013","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/23744056","citation_count":15,"is_preprint":false},{"pmid":"17327490","id":"PMC_17327490","title":"Transcription factor CHF1/Hey2 regulates the global transcriptional response to platelet-derived growth factor in vascular smooth muscle cells.","date":"2007","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17327490","citation_count":15,"is_preprint":false},{"pmid":"23782701","id":"PMC_23782701","title":"Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23782701","citation_count":15,"is_preprint":false},{"pmid":"28552883","id":"PMC_28552883","title":"SEL1L-dependent Substrates Require Derlin2/3 and Herp1/2 for Endoplasmic Reticulum-associated Degradation.","date":"2017","source":"Cell structure and function","url":"https://pubmed.ncbi.nlm.nih.gov/28552883","citation_count":14,"is_preprint":false},{"pmid":"32035085","id":"PMC_32035085","title":"Expression of Hey2 transcription factor in the early embryonic ventricles is controlled through a distal enhancer by Tbx20 and Gata transcription factors.","date":"2020","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32035085","citation_count":14,"is_preprint":false},{"pmid":"32820247","id":"PMC_32820247","title":"Germline variants in HEY2 functional domains lead to congenital heart defects and thoracic aortic aneurysms.","date":"2020","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32820247","citation_count":13,"is_preprint":false},{"pmid":"25832314","id":"PMC_25832314","title":"Duplication of HEY2 in cardiac and neurologic development.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25832314","citation_count":12,"is_preprint":false},{"pmid":"26729854","id":"PMC_26729854","title":"Common Variant Near HEY2 Has a Protective Effect on Ventricular Fibrillation Occurrence in Brugada Syndrome by Regulating the Repolarization Current.","date":"2016","source":"Circulation. Arrhythmia and electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/26729854","citation_count":12,"is_preprint":false},{"pmid":"33410138","id":"PMC_33410138","title":"A role of Hey2 transcription factor for right ventricle development through regulation of Tbx2-Mycn pathway during cardiac morphogenesis.","date":"2021","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/33410138","citation_count":11,"is_preprint":false},{"pmid":"22408025","id":"PMC_22408025","title":"Transcription factor CHF1/Hey2 regulates EC coupling and heart failure in mice through regulation of FKBP12.6.","date":"2012","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22408025","citation_count":11,"is_preprint":false},{"pmid":"20619341","id":"PMC_20619341","title":"Transcription factor CHF1/Hey2 regulates coronary vascular maturation.","date":"2010","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/20619341","citation_count":11,"is_preprint":false},{"pmid":"20001863","id":"PMC_20001863","title":"CHF1/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways.","date":"2009","source":"Omics : a journal of integrative biology","url":"https://pubmed.ncbi.nlm.nih.gov/20001863","citation_count":11,"is_preprint":false},{"pmid":"15643620","id":"PMC_15643620","title":"ZFPM2/FOG2 and HEY2 genes analysis in nonsyndromic tricuspid atresia.","date":"2005","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/15643620","citation_count":10,"is_preprint":false},{"pmid":"32975900","id":"PMC_32975900","title":"Sox2-dependent maintenance of mouse oligodendroglioma involves the Sox2-mediated downregulation of Cdkn2b, Ebf1, Zfp423, and Hey2.","date":"2020","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/32975900","citation_count":9,"is_preprint":false},{"pmid":"24890415","id":"PMC_24890415","title":"BMP signaling participates in late phase differentiation of the retina, partly via upregulation of Hey2.","date":"2014","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24890415","citation_count":9,"is_preprint":false},{"pmid":"21119893","id":"PMC_21119893","title":"Transcription Factor CHF1/Hey2 Regulates Specific Pathways in Serum Stimulated Primary Cardiac Myocytes: Implications for Cardiac Hypertrophy.","date":"2010","source":"Current genomics","url":"https://pubmed.ncbi.nlm.nih.gov/21119893","citation_count":8,"is_preprint":false},{"pmid":"23288164","id":"PMC_23288164","title":"Hesr2 knockout mice develop aortic valve disease with advancing age.","date":"2013","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23288164","citation_count":8,"is_preprint":false},{"pmid":"29155305","id":"PMC_29155305","title":"Hey1 and Hey2 are differently expressed during mouse tooth development.","date":"2017","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/29155305","citation_count":7,"is_preprint":false},{"pmid":"37669370","id":"PMC_37669370","title":"Hey2 enhancer activity defines unipotent progenitors for left ventricular cardiomyocytes in juxta-cardiac field of early mouse embryo.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37669370","citation_count":7,"is_preprint":false},{"pmid":"35912776","id":"PMC_35912776","title":"HIF-2α Inhibits Ameloblast Differentiation via Hey2 in Tooth Development.","date":"2022","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/35912776","citation_count":6,"is_preprint":false},{"pmid":"30955100","id":"PMC_30955100","title":"A Novel Somatic Variant in HEY2 Unveils an Alternative Splicing Isoform Linked to Ventricular Septal Defect.","date":"2019","source":"Pediatric cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/30955100","citation_count":6,"is_preprint":false},{"pmid":"31396342","id":"PMC_31396342","title":"HEY2 acting as a co-repressor with smad3 and smad4 interferes with the response of TGF-beta in hepatocellular carcinoma.","date":"2019","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/31396342","citation_count":6,"is_preprint":false},{"pmid":"22079635","id":"PMC_22079635","title":"Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22079635","citation_count":5,"is_preprint":false},{"pmid":"39495146","id":"PMC_39495146","title":"MicroRNA-181b-5p/HEY2 axis is involved in the progress of deep venous thrombosis via mediating vascular endothelial injury.","date":"2024","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/39495146","citation_count":3,"is_preprint":false},{"pmid":"21362320","id":"PMC_21362320","title":"Effects of hepatocyte growth factor-mediated activation of Dll4-Notch-Hey2 signaling pathway.","date":"2011","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/21362320","citation_count":2,"is_preprint":false},{"pmid":"37649203","id":"PMC_37649203","title":"Genetic lineage tracing in skin reveals predominant expression of HEY2 in dermal papilla during telogen and that HEY2+ cells contribute to the regeneration of dermal cells during wound healing.","date":"2023","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/37649203","citation_count":2,"is_preprint":false},{"pmid":"40441591","id":"PMC_40441591","title":"Super-enhancers and Mef2c: Novel regulators of cardiac hypertrophy via the Hey2/Notch/p38 signaling pathway.","date":"2025","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40441591","citation_count":1,"is_preprint":false},{"pmid":"40481234","id":"PMC_40481234","title":"A novel heterozygous pathogenic variant in HEY2 led to a familial form of non-syndromic Tetralogy of Fallot.","date":"2025","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/40481234","citation_count":1,"is_preprint":false},{"pmid":"32997309","id":"PMC_32997309","title":"Notch-HEY2 signaling pathway contributes to the differentiation of CD34+ hematopoietic-like stem cells from adult peripheral blood insulin-producing cells after the treatment with platelet-derived mitochondria.","date":"2020","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/32997309","citation_count":0,"is_preprint":false},{"pmid":"38314334","id":"PMC_38314334","title":"Notch-1/2 receptors and Jagged-1 ligand, but not HERP-1 transcription factor, are immunohistochemically expressed in the epithelial lining of periapical cysts.","date":"2024","source":"Journal of clinical and experimental dentistry","url":"https://pubmed.ncbi.nlm.nih.gov/38314334","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.07.681046","title":"Genetic Determinants of Heart Failure Susceptibility and Response in the Collaborative Cross Mouse Population","date":"2025-10-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.07.681046","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.22.655570","title":"Patterning defects in mice with defective ventricular wall maturation and cardiomyopathy","date":"2025-05-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.22.655570","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":38741,"output_tokens":8420,"usd":0.121261},"stage2":{"model":"claude-opus-4-6","input_tokens":12251,"output_tokens":4119,"usd":0.246345},"total_usd":0.367606,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Hey1 and Hey2 are essential downstream transducers of Notch signaling in cardiovascular development; combined loss of Hey1 and Hey2 in mice causes embryonic lethality with global failure of vascular remodeling, and remaining arteries fail to express arterial endothelial markers CD44, neuropilin1, and ephrin-B2, establishing Hey1/Hey2 as mediators of arterial cell fate decision downstream of Notch1/Jagged1 signaling.\",\n      \"method\": \"Mouse knockout (Hey1-/-, Hey2-/-, Hey1/Hey2 double KO), genetic epistasis with Notch1 and Jagged1 knockouts, in situ hybridization for arterial markers\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined vascular phenotype, replicated across multiple genotypes and epistasis experiments\",\n      \"pmids\": [\"15107403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hey2 (gridlock ortholog) is required for cardiac morphogenesis; targeted disruption in mice produces ventricular septal defects, tetralogy of Fallot, and tricuspid atresia, establishing Hey2 as an important regulator of cardiac septation and morphogenesis downstream of the Notch/JAG1 pathway.\",\n      \"method\": \"Gene targeting (mouse knockout), histological and morphological analysis\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with well-defined cardiac phenotype, independently confirmed by multiple labs\",\n      \"pmids\": [\"12372254\", \"12454287\", \"12372253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Loss of Hey2 (CHF1) in mice causes ventricular septal defects and cardiomyopathy, with surviving adult animals developing impaired myocardial contractility, demonstrating CHF1/Hey2 plays a role in regulation of ventricular septation and normal myocardial function.\",\n      \"method\": \"Targeted gene disruption (mouse KO), histology, echocardiography, survival analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cardiac phenotype replicated across multiple labs\",\n      \"pmids\": [\"12454287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SIRT1 physically associates with HEY2 (and HES1) both in vitro and in vivo, and both SIRT1-dependent and SIRT1-independent deacetylase pathways are involved in HEY2-mediated transcriptional repression, demonstrating that the bHLH repressor–Sir2 interaction is conserved from Drosophila to humans.\",\n      \"method\": \"Co-immunoprecipitation (in vitro and in vivo), reporter/transfection assays with deacetylase inhibitors\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — reciprocal Co-IP plus functional reporter assay, single lab\",\n      \"pmids\": [\"12535671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Misexpression of Hesr2/Hey2 in mouse brain transiently maintains neural precursor cells, inhibits transcription induced by neuronal bHLH genes Mash1 and Math3 (in transfection assay), and promotes maintenance of neural progenitors, thereby increasing late-born neurons and subsequently astroglial cells.\",\n      \"method\": \"In utero electroporation (misexpression), transient transfection reporter assays, in situ hybridization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function in vivo with defined cellular phenotype plus in vitro mechanistic assay\",\n      \"pmids\": [\"12947105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"HERP1/HEY2 is a direct primary target gene of Notch signaling in A10 smooth muscle cells: Notch intracellular domain (NICD) activates the HERP1 promoter in an RBP-Jκ-dependent manner, induces endogenous HERP1 mRNA and protein even without de novo protein synthesis, and RBP-Jκ is required for induction.\",\n      \"method\": \"Promoter-reporter assays, co-culture with Notch ligand-expressing cells, cycloheximide treatment, RBP-Jκ-deficient cell rescue experiments, RT-PCR\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — multiple orthogonal methods (promoter assay, endogenous mRNA induction, cycloheximide, genetic rescue) in a single study\",\n      \"pmids\": [\"11741889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HERP1/HEY2 inhibits myocardin-induced vascular smooth muscle cell differentiation by physically interacting with SRF and interfering with SRF binding to CArG-box elements in SMC marker gene promoters.\",\n      \"method\": \"Co-immunoprecipitation, EMSA (electrophoretic mobility shift assay), reporter assays, overexpression in 10T1/2 cells, immunohistochemistry\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — direct protein interaction (Co-IP), DNA-binding interference (EMSA), and functional reporter assay in same study\",\n      \"pmids\": [\"16151017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CHF1/Hey2 deficiency in mice reduces neointima formation after arterial wire injury and impairs VSMC proliferation and PDGF/HB-EGF-induced migration, correlating with decreased Rac1 GTPase activation and reduced levels of the Rac GEF Sos1.\",\n      \"method\": \"Mouse KO, wire injury model, in vitro VSMC migration/proliferation assays, Rac1 activation assay, western blot for Sos1\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined in vivo and in vitro phenotypes plus molecular pathway dissection\",\n      \"pmids\": [\"15345511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Hey1/Hey2 proteins directly homo- and heterodimerize with each other and with other hairy-related bHLH proteins (c-hairy1), as shown by in vitro and in vivo interaction assays, suggesting combinatorial action in the segmentation clock and somite patterning.\",\n      \"method\": \"In vitro and in vivo interaction assays (co-immunoprecipitation/pull-down), in situ hybridization in Dll1 and Notch1 knockout mice\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — direct protein interaction assays, single study\",\n      \"pmids\": [\"11076679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CHF1/Hey2 overexpression in transgenic mouse myocardium suppresses phenylephrine-induced cardiac hypertrophy; mechanistically, CHF1/Hey2 directly binds GATA4 (by co-immunoprecipitation), inhibits GATA4 binding to its recognition sequence in the ANF promoter, and suppresses GATA4-dependent induction of hypertrophy marker genes (ANF, BNP, β-MHC).\",\n      \"method\": \"Transgenic mouse overexpression, isolated neonatal myocyte assays, co-immunoprecipitation, reporter assays with GATA4\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — direct protein interaction (Co-IP), DNA-binding inhibition, in vivo and in vitro functional phenotype converge\",\n      \"pmids\": [\"16603706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CHF1/Hey2 suppresses GATA-6-dependent smooth-muscle myosin heavy chain (SM-MHC) promoter activity through direct physical interaction with GATA-6 (co-immunoprecipitation); the bHLH domain of CHF1/Hey2 is required for this transcriptional repression.\",\n      \"method\": \"Co-immunoprecipitation, cotransfection reporter assays, bHLH domain mutational analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein interaction plus mutational dissection, single lab\",\n      \"pmids\": [\"16293227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Foxc2 directly activates the Hey2 promoter via conserved Foxc binding elements; Foxc2 physically and functionally interacts with the Notch transcriptional activation complex (Su(H)/NICD) to induce Hey2 promoter activity; VEGF-activated PI3K and ERK pathways modulate Foxc transcriptional activity in Hey2 induction.\",\n      \"method\": \"Promoter-reporter assays, co-immunoprecipitation, chromatin immunoprecipitation (ChIP), EMSA, endothelial cell transfection\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — multiple orthogonal methods (ChIP, Co-IP, EMSA, reporter) in single study\",\n      \"pmids\": [\"18545664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Hypoxia induces Dll4 and Hey2 expression via HIF-1α; Hey2 in endothelial progenitor cells represses COUP-TFII (venous identity regulator), promoting arterial cell fate; Hey factors in turn repress HIF-1α-induced gene expression, creating a negative feedback loop in the Dll4-Notch-Hey2 signaling cascade.\",\n      \"method\": \"Hypoxia treatment of cell lines, promoter analysis (HIF-1α binding sites), co-culture/overexpression experiments, quantitative RT-PCR\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — promoter analysis plus functional overexpression, single lab\",\n      \"pmids\": [\"17045587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Forced expression of Hesr2/Hey2 throughout the cardiac lineage in mice suppresses Tbx2 and Bmp2 expression and eliminates the atrioventricular (AV) canal, demonstrating that Hey2 directly suppresses Tbx2 to regulate AV boundary formation; this regulation is independent of Notch2 signaling.\",\n      \"method\": \"Myocardial misexpression transgenic mice, in situ hybridization, genetic epistasis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined loss/gain-of-function cardiac phenotype with molecular target identification, epistasis with Notch2\",\n      \"pmids\": [\"17259303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Combined knockout of Hesr1 and Hesr2/Hey2 in mice is embryonic lethal at E11.5 and recapitulates most cardiovascular phenotypes of disrupted Notch pathway mutants (arterial-venous specification defects, septation, cushion formation), demonstrating functional redundancy between Hey1 and Hey2 as downstream effectors of Notch signaling in cardiovascular development.\",\n      \"method\": \"Mouse double knockout, in situ hybridization, histological analysis, genetic epistasis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double KO with defined cardiovascular phenotype, epistasis with Notch pathway\",\n      \"pmids\": [\"15680351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Hey2 expression in cochlear pillar cells is maintained by FGF signaling independently of Notch; Hey2 blocks hair cell differentiation, and mutation of Hey2 makes pillar cells sensitive to loss of Notch signaling allowing them to differentiate as hair cells, placing Hey2 downstream of FGF but independent of Notch in pillar cell fate maintenance.\",\n      \"method\": \"Mouse knockout, Notch inhibitor treatment, FGF treatment, cochlear explant cultures, cell fate tracing\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined cellular phenotype, pharmacological Notch inhibition, FGF stimulation, multiple methods\",\n      \"pmids\": [\"19154718\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TAp73 promotes long-term neural stem cell maintenance by transcriptionally regulating Hey2; Hey2 downstream of TAp73 prevents premature differentiation of neural precursors, establishing a TAp73→Hey2 transcriptional axis in adult neurogenesis.\",\n      \"method\": \"Mouse KO (TAp73), neural stem cell isolation, overexpression/knockdown of Hey2, BrdU incorporation, differentiation assays\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with defined cellular phenotype, Hey2 as direct transcriptional target validated by rescue experiments\",\n      \"pmids\": [\"21074438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In zebrafish, Hey2 is required upstream of Notch for hematopoietic stem cell (HSC) formation in the dorsal aorta; Hey2 expression is induced downstream of cloche/Scl and maintained by Hedgehog and VEGF signaling; knockdown of Hey2 reduces Notch receptor expression in aortic angioblasts, and Notch activation rescues HSC formation in hey2 morphants.\",\n      \"method\": \"Zebrafish morpholino knockdown, Notch activation (genetic rescue), in situ hybridization, epistasis analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — morpholino KD with defined HSC phenotype, genetic epistasis placing Hey2 upstream of Notch\",\n      \"pmids\": [\"20511544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CHF1/Hey2 regulates MMP10 expression through multiple E-box elements in the MMP10 promoter; loss/knockdown of CHF1/Hey2 increases MMP10 expression and activity in VSMCs; mutation of E-boxes abolishes repression and unmasks an activator function for CHF1/Hey2.\",\n      \"method\": \"KO/siRNA knockdown, promoter-reporter assays, E-box mutagenesis, MMP10 activity assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assays with site-directed mutagenesis plus endogenous gene expression analysis\",\n      \"pmids\": [\"22079635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Conditional myocardial knockout of CHF1/Hey2 causes abnormalities in calcium handling after pressure overload, mediated by increased FKBP12.6 expression; treatment with FK506 (which inhibits FKBP12.6 association with ryanodine receptor) restored contractile function in KO cardiomyocytes, linking CHF1/Hey2 to EC coupling via FKBP12.6.\",\n      \"method\": \"Conditional myocardial KO mice, aortic banding, isolated cardiomyocyte calcium transient measurements, FK506 pharmacological rescue, quantitative RT-PCR\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined functional phenotype plus pharmacological rescue identifying molecular mechanism\",\n      \"pmids\": [\"22408025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hey2 regulates bone remodeling: conditional osteoblast-specific Hey2 deletion increases trabecular bone volume and suppresses alkaline phosphatase (ALPL) activity; Hey2 transgenic overexpression in osteoblasts decreases osteoblast activity, increases bone resorption, and induces IL-6 (promoting osteoclastogenesis) in a sex-dependent manner.\",\n      \"method\": \"Conditional KO (Osx-Cre and Oc-Cre), transgenic overexpression, bone histomorphometry, ALPL activity assays, osteoclastogenesis co-culture assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO and transgenic OE with defined bone phenotype and molecular readout, single lab\",\n      \"pmids\": [\"23782701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"COUP-TFII directly binds the Hey2 promoter and downregulates Hey2 expression in arterial endothelial cells, as shown by ChIP, EMSA, and promoter analysis; Hey2 in turn regulates EphrinB2 expression downstream, placing Hey2 as part of the COUP-TFII→Hey2→EphrinB2 arteriovenous specification hierarchy.\",\n      \"method\": \"ChIP, EMSA, promoter analysis, lentiviral overexpression/shRNA knockdown in human endothelial cells, qRT-PCR\",\n      \"journal\": \"Basic research in cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + EMSA + functional promoter assay in human endothelial cells\",\n      \"pmids\": [\"23744056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Conditional double knockout of Hey1 and Hey2 in prosensory cochlear cells causes premature upregulation of the pro-hair cell factor Atoh1 and premature hair cell differentiation, establishing Hey1/Hey2 as suppressors of Atoh1 in cochlear progenitor maintenance; this prosensory expression and its graded downregulation is controlled by Hedgehog signaling in a largely FGFR-dependent manner.\",\n      \"method\": \"Conditional double knockout (Hey1/Hey2), in situ hybridization, immunofluorescence, FGFR pharmacological inhibition\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional double KO with defined molecular and cellular phenotype, pathway epistasis\",\n      \"pmids\": [\"25232121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Myocardial-specific deletion of CHF1/Hey2 results in 50% reduction in cardiomyocyte action potential dV/dT, 50-75% reduction in SCN5A, KCNJ2, and CACNA1C ion channel subunit gene expression, increased delayed afterdepolarizations, and ~3-fold expansion of cardiac conduction system tissue, linking CHF1/Hey2 to transcriptional regulation of cardiac ion channel genes.\",\n      \"method\": \"Myocardial-specific conditional KO, patch clamp electrophysiology, qRT-PCR for ion channel gene expression, CCS-LacZ reporter cross\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — conditional KO with electrophysiological and molecular phenotypes, multiple orthogonal methods\",\n      \"pmids\": [\"24687990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Serum/BMP9 induces Hey1 and Hey2 transcription in endothelial cells through Alk1 (BMP receptor) signaling independently of canonical Notch (gamma-secretase or dominant-negative MAML1 did not prevent induction), identifying BMP/Alk1 as a Notch-independent upstream activator of Hey2 in endothelial cells.\",\n      \"method\": \"Gamma-secretase inhibition, dominant-negative MAML1 expression, soluble Alk1/Alk3 receptor treatment, BMP9 stimulation, qRT-PCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological and genetic pathway inhibition with multiple controls, single lab\",\n      \"pmids\": [\"25799559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HEY2 controls normal transmural electrophysiological gradient in the ventricle: Hey2+/- mice show reduced expression of Kcnip2 and Kcnd2 (Ito subunits) in subepicardium, diminished transmural Ito differences and J-wave amplitude; in humans, Brugada syndrome risk allele at rs9388451 associates with increased HEY2 expression, and HEY2 coexpression with KCNIP2 is the strongest genome-wide correlate, identifying a HEY2→KCNIP2 ion channel patterning axis.\",\n      \"method\": \"Heterozygous KO mice, patch-clamp electrophysiology (subepicardial vs. subendocardial cardiomyocytes), surface ECG, genome-wide coexpression analysis, eQTL analysis in human LV samples\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — KO electrophysiology, human eQTL, and genome-wide coexpression converge on same mechanism\",\n      \"pmids\": [\"28637782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Hey2 overexpression is sufficient to induce endothelial-to-mesenchymal transition (EndoMT) in HUVECs; endothelial-specific conditional deletion of Hey2 in mice reduces EndoMT frequency and mitigates radiation-induced proctitis, demonstrating a causal role for Hey2 in driving EndoMT.\",\n      \"method\": \"siRNA knockdown and plasmid overexpression in HUVECs, Cre-LoxP endothelial-specific KO mice, irradiation model, immunocytochemistry, western blot, qPCR\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function and conditional KO with defined EndoMT phenotype in vitro and in vivo\",\n      \"pmids\": [\"28694461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HEY2 is a key mediator of NKX2-5 function during human cardiomyogenesis: NKX2-5 deletion in hESCs impairs cardiomyogenesis and HEY2 expression; molecular profiling and genetic rescue experiments demonstrate HEY2 acts downstream of NKX2-5 in the cardiac transcriptional network to enable VCAM1 activation and PDGFRα downregulation.\",\n      \"method\": \"hESC gene deletion (NKX2-5 null), molecular profiling, genetic rescue (HEY2 overexpression), action potential recording, gene expression analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human ESC KO plus genetic rescue with molecular profiling, multiple methods\",\n      \"pmids\": [\"29636455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Notch signaling and Nrg1/ErbB2 regulate Hey2 expression level (but not pattern) in myocardium/endocardium; FGF signaling regulates Hey2 expression pattern in early myocardium and also regulates Hey2 level in a Notch1-dependent manner; Hey2 is expressed in endocardial cells of AV canal, outflow tract, and base of trabeculae in addition to compact myocardium.\",\n      \"method\": \"RNAscope in situ hybridization, Hey2-CreERT2 knockin lineage tracing, pathway disruption (Notch, FGF, Nrg1/ErbB2 inhibition/KO)\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — novel lineage tracing tool plus multiple pathway epistasis experiments, single lab\",\n      \"pmids\": [\"29422515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HEY2 forms complexes with Smad3 and Smad4 and represses Smad3/Smad4 transcriptional activity, thereby inhibiting TGF-β-induced growth arrest and c-Myc downregulation in hepatocellular carcinoma cells; HEY2 overexpression suppresses TGF-β biological responses while HEY2 knockdown enhances them.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown and overexpression, reporter assays, western blot, qRT-PCR\",\n      \"journal\": \"American journal of translational research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — protein complex (Co-IP) plus functional gain/loss-of-function with defined pathway readout, single lab\",\n      \"pmids\": [\"31396342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A distal Hey2 enhancer conserved in mouse and human drives ventricular free-wall myocyte-specific expression; this enhancer requires conserved T-box and Gata binding sites (not NK-2 sites), and Tbx20 is required for enhancer activity in embryonic ventricles; Tbx20 cooperates with cardiac GATA proteins to control the ventricular enhancer.\",\n      \"method\": \"Enhancer deletion in mice (CRISPR), in vivo reporter assays, site-directed mutagenesis of binding sites, Tbx20 null mice, luciferase reporter assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — in vivo enhancer deletion, mutational analysis, and epistasis with Tbx20 KO in single study\",\n      \"pmids\": [\"32035085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Germline loss-of-function variants in HEY2 functional domains disrupt its repressive activity (shown by reporter gene assay) and cause congenital heart defects and thoracic aortic aneurysms in humans, with heterozygous carriers showing cardiovascular defects at high penetrance.\",\n      \"method\": \"Genome sequencing, gene-based association test (MetaSKAT), reporter/expression assays for variant functional consequences\",\n      \"journal\": \"Genetics in medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — human variant with functional reporter assay validation, single study\",\n      \"pmids\": [\"32820247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Hey2 conditional KO in the right ventricle/outflow tract (Mef2c-AHF-Cre) causes right ventricular hypoplasia; RNA-seq reveals ectopic induction of Tbx2 in the RV chamber myocardium, leading to reduced Mycn expression and decreased S-phase cells, establishing a Hey2→Tbx2→Mycn pathway controlling RV cardiomyocyte proliferation.\",\n      \"method\": \"Conditional KO (Mef2c-AHF-Cre), RNA-seq, in situ hybridization, BrdU incorporation, histology\",\n      \"journal\": \"Development, growth & differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with unbiased transcriptomic pathway discovery and cellular proliferation readout\",\n      \"pmids\": [\"33410138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HEY2 enriches at promoters of metabolic genes (Ppargc1/PGC-1α, Esrra, Cpt1) and colocalizes with HDAC1 to effectuate histone deacetylation and transcriptional repression of mitochondrial oxidation genes; HEY2-induced impairment of mitochondrial respiration causes elevated ROS and cardiomyocyte apoptosis; restoration of PPARGC1A/ESRRA rescues bioenergetic deficits, defining an HEY2/HDAC1–Ppargc1/Cpt1 transcriptional module controlling cardiac energy metabolism.\",\n      \"method\": \"Genome-wide ChIP-seq, ATAC-seq, Hi-C, CUT&RUN; conditional KO and overexpression in zebrafish and mouse; mitochondrial respiration assays; doxorubicin cardiac injury model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple genome-wide chromatin assays, in vivo KO/OE, functional metabolic rescue, replicated across species\",\n      \"pmids\": [\"39747914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A novel HEY2 missense variant (p.Glu57Asp) completely disrupts HEY2 repressive transcriptional activity in a reporter gene assay and segregates with non-syndromic Tetralogy of Fallot in a family, confirming that HEY2 repressor function is required for normal conotruncal cardiac development.\",\n      \"method\": \"Sanger sequencing, gene reporter assay (loss of repression), family segregation analysis\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single variant with functional reporter assay, single study\",\n      \"pmids\": [\"40481234\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HEY2 is a bHLH transcriptional repressor that acts as a direct downstream target of Notch (and, independently, FGF/BMP/Alk1) signaling to regulate arterial cell fate, cardiac morphogenesis (ventricular septation, RV development, AV canal), and ion channel patterning (KCNIP2/Ito, SCN5A); it represses target genes by recruiting HDAC1 to promoters (including PGC-1α/CPT1 metabolic genes), and inhibits the activity of GATA4, GATA-6, SRF/myocardin, and Smad3/Smad4 complexes through direct protein–protein interactions, thereby suppressing pathological cardiac hypertrophy, vascular smooth muscle dedifferentiation, and mitochondrial metabolic reprogramming.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HEY2 is a bHLH transcriptional repressor that serves as a central effector of Notch, FGF, BMP/Alk1, and Hedgehog signaling in cardiovascular development, neural progenitor maintenance, and cochlear cell fate determination. It represses target gene transcription by binding E-box elements and recruiting HDAC1 to promoters of metabolic genes (PGC-1α, CPT1) and ion channel genes (KCNIP2, SCN5A), and it antagonizes the transcriptional activities of GATA4, GATA-6, SRF/myocardin, and Smad3/Smad4 through direct protein–protein interactions, thereby suppressing cardiac hypertrophy, vascular smooth muscle dedifferentiation, and TGF-β signaling [PMID:16603706, PMID:16293227, PMID:39747914, PMID:31396342, PMID:28637782]. In the developing heart, Hey2 maintains ventricular chamber identity by suppressing Tbx2 to sustain cardiomyocyte proliferation and regulates atrioventricular canal boundary formation, ventricular septation, and conduction system patterning; its loss causes ventricular septal defects, tetralogy of Fallot, right ventricular hypoplasia, and cardiomyopathy [PMID:12454287, PMID:17259303, PMID:33410138, PMID:24687990]. Germline loss-of-function variants in HEY2 cause congenital heart defects including tetralogy of Fallot and thoracic aortic aneurysms in humans [PMID:32820247, PMID:40481234].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"How Hey2 is activated was unknown; demonstration that Notch intracellular domain directly induces HEY2 transcription through RBP-Jκ-dependent promoter activation — even without de novo protein synthesis — established HEY2 as a primary transcriptional target of Notch signaling.\",\n      \"evidence\": \"Promoter-reporter assays, cycloheximide treatment, RBP-Jκ-deficient cell rescue in smooth muscle cells\",\n      \"pmids\": [\"11741889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other pathways independently activate Hey2 was not addressed\", \"Chromatin-level regulation of the Hey2 locus not examined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"The in vivo requirement of Hey2 was uncertain; targeted disruption in mice revealed ventricular septal defects, tetralogy of Fallot, tricuspid atresia, and adult cardiomyopathy, establishing Hey2 as essential for cardiac septation and myocardial function.\",\n      \"evidence\": \"Mouse knockout, histology, echocardiography across multiple independent labs\",\n      \"pmids\": [\"12372254\", \"12454287\", \"12372253\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Hey2 acts cell-autonomously in cardiomyocytes versus other cardiac cell types was unresolved\", \"Direct transcriptional targets in heart unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"The mechanism of Hey2-mediated repression was unclear; discovery that SIRT1 physically associates with HEY2 and participates in its repressive activity revealed that deacetylase recruitment is a key component of Hey2 transcriptional repression.\",\n      \"evidence\": \"Co-immunoprecipitation (in vitro and in vivo), reporter assays with deacetylase inhibitors\",\n      \"pmids\": [\"12535671\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of SIRT1-dependent vs. SIRT1-independent deacetylation not quantified\", \"No genome-wide target identification\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Whether Hey genes mediate Notch-dependent arterial identity was unknown; combined Hey1/Hey2 knockout recapitulated Notch1/Jagged1 vascular phenotypes with loss of arterial markers (ephrin-B2, neuropilin1), establishing Hey1/Hey2 as essential Notch effectors for arterial-venous specification.\",\n      \"evidence\": \"Hey1/Hey2 double KO mice, genetic epistasis with Notch1 and Jagged1 knockouts, arterial marker in situ hybridization\",\n      \"pmids\": [\"15107403\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Hey2 directly represses venous genes or activates arterial genes was not distinguished\", \"Endothelial cell-autonomous requirement not tested with conditional KO\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"How Hey2 suppresses smooth muscle differentiation was mechanistically unclear; demonstration that HEY2 physically binds SRF and blocks SRF-CArG box interaction revealed a direct protein–protein interference mechanism inhibiting myocardin-induced VSMC gene activation.\",\n      \"evidence\": \"Co-immunoprecipitation, EMSA, reporter assays in 10T1/2 cells\",\n      \"pmids\": [\"16151017\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this mechanism operates in vivo during vascular development was not shown\", \"Which Hey2 domain mediates SRF interaction was not mapped\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Whether Hey2 modulates cardiac hypertrophy was unknown; transgenic overexpression of Hey2 suppressed phenylephrine-induced hypertrophy by directly binding GATA4 and blocking its DNA binding at hypertrophy gene promoters (ANF, BNP, β-MHC).\",\n      \"evidence\": \"Transgenic mouse, neonatal myocyte assays, co-immunoprecipitation, reporter assays\",\n      \"pmids\": [\"16603706\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endogenous Hey2 loss enhances hypertrophy in vivo was not tested\", \"Interaction with other GATA family members (GATA-6) in hypertrophy context not explored in this study\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"How the AV canal boundary is established was poorly understood; forced Hey2 expression throughout the heart eliminated the AV canal by suppressing Tbx2 and Bmp2, defining Hey2 as a chamber-specific repressor of AV canal identity independent of Notch2.\",\n      \"evidence\": \"Transgenic misexpression mice, in situ hybridization, Notch2 epistasis\",\n      \"pmids\": [\"17259303\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Hey2 directly binds the Tbx2 promoter was not shown\", \"Whether Hey2 repression of Tbx2 is sufficient or requires cofactors was not addressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The upstream transcription factor network controlling Hey2 in endothelial cells was incompletely mapped; Foxc2 was shown to directly bind the Hey2 promoter and cooperate with the Notch transcriptional complex to activate Hey2 expression, integrating VEGF-PI3K/ERK signaling into Hey2 regulation.\",\n      \"evidence\": \"ChIP, EMSA, promoter-reporter assays, co-immunoprecipitation in endothelial cells\",\n      \"pmids\": [\"18545664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Foxc2 is required for Hey2 expression in vivo was not tested\", \"Relative contribution of Foxc2 versus RBP-Jκ at the endogenous locus unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Whether Hey2 functions independently of Notch was uncertain in non-vascular contexts; in the cochlea, FGF signaling maintains Hey2 expression in pillar cells independently of Notch, and Hey2 loss sensitizes these cells to Notch inhibition, revealing a Notch-independent FGF–Hey2 axis in auditory cell fate.\",\n      \"evidence\": \"Mouse knockout, cochlear explant cultures with Notch inhibitor and FGF treatment\",\n      \"pmids\": [\"19154718\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FGF directly activates Hey2 transcription or acts through intermediary factors was not resolved\", \"Whether other Hey family members compensate in cochlea was not fully explored\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Hey2's role in cardiac electrophysiology was unknown; conditional myocardial deletion revealed 50–75% reduction in SCN5A, KCNJ2, and CACNA1C expression with reduced action potential upstroke velocity and conduction system expansion, establishing Hey2 as a transcriptional regulator of cardiac ion channel gene expression.\",\n      \"evidence\": \"Myocardial-specific conditional KO, patch clamp, qRT-PCR, CCS-LacZ reporter\",\n      \"pmids\": [\"24687990\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Hey2 directly binds ion channel gene promoters was not shown\", \"Whether ion channel phenotype contributes to arrhythmia susceptibility in humans was not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The mechanism behind transmural electrophysiological heterogeneity in the ventricle was unclear; Hey2 haploinsufficiency in mice reduced subepicardial KCNIP2/Ito expression, and human eQTL analysis linked the HEY2 Brugada syndrome risk locus to HEY2–KCNIP2 coexpression, identifying a HEY2→KCNIP2 axis controlling transmural Ito gradient and Brugada syndrome susceptibility.\",\n      \"evidence\": \"Hey2+/− mice, subepicardial/subendocardial patch clamp, human left ventricular eQTL, genome-wide coexpression analysis\",\n      \"pmids\": [\"28637782\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HEY2 directly binds the KCNIP2 regulatory region was not demonstrated\", \"Functional rescue of Brugada phenotype by KCNIP2 restoration not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Cis-regulatory logic controlling ventricular Hey2 expression was undefined; a conserved distal enhancer requiring T-box (Tbx20) and GATA binding sites — but not NK-2 sites — was identified, revealing Tbx20/GATA as upstream activators at the chromatin level.\",\n      \"evidence\": \"CRISPR enhancer deletion in mice, site-directed mutagenesis, Tbx20 null mice, in vivo reporter assays\",\n      \"pmids\": [\"32035085\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional enhancers control Hey2 expression in other cardiac compartments was not addressed\", \"3D chromatin architecture at the Hey2 locus not characterized in this study\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Whether HEY2 variants cause human congenital heart disease was unresolved; germline loss-of-function variants disrupting HEY2 repressor activity were identified in patients with congenital heart defects and thoracic aortic aneurysms, establishing HEY2 as a human disease gene.\",\n      \"evidence\": \"Genome sequencing, gene-based association (MetaSKAT), reporter assay for functional variant assessment\",\n      \"pmids\": [\"32820247\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Small cohort size limits genotype–phenotype correlation\", \"No animal model rescue of specific human variants performed\", \"Mechanism by which loss of HEY2 causes aortic aneurysm not addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"How Hey2 controls right ventricular growth was mechanistically unknown; conditional RV-specific deletion showed ectopic Tbx2 induction leading to Mycn downregulation and reduced cardiomyocyte proliferation, defining a Hey2⊣Tbx2⊣Mycn pathway governing RV expansion.\",\n      \"evidence\": \"Mef2c-AHF-Cre conditional KO, RNA-seq, BrdU incorporation, in situ hybridization\",\n      \"pmids\": [\"33410138\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Hey2 directly binds the Tbx2 locus or acts indirectly was not resolved\", \"Whether the same pathway operates in left ventricle was not tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The chromatin mechanism of Hey2-mediated metabolic gene repression was unknown; genome-wide ChIP-seq revealed HEY2 occupancy at PGC-1α, ESRRA, and CPT1 promoters with colocalized HDAC1, mediating histone deacetylation and repression of mitochondrial oxidation genes; this causes impaired respiration, elevated ROS, and cardiomyocyte apoptosis, rescued by PPARGC1A/ESRRA restoration.\",\n      \"evidence\": \"ChIP-seq, ATAC-seq, Hi-C, CUT&RUN, conditional KO and overexpression in zebrafish and mouse, mitochondrial respiration assays, doxorubicin injury model\",\n      \"pmids\": [\"39747914\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HDAC1 recruitment is sufficient or whether SIRT1 also participates at metabolic gene loci was not tested\", \"Whether metabolic reprogramming contributes to the cardiac phenotypes of Hey2 KO mice was not directly addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: whether HEY2 directly binds the promoters of Tbx2, KCNIP2, and SCN5A or acts through intermediary factors; the structural basis for HEY2 selectivity among its diverse protein partners (GATA4, SRF, Smad3); and whether HEY2 metabolic target repression contributes to congenital heart disease pathogenesis in humans.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of HEY2 or its complexes\", \"Direct binding at Tbx2, KCNIP2, SCN5A loci not demonstrated by ChIP\", \"Genotype–phenotype correlations in humans limited by small cohort sizes\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [5, 6, 9, 10, 13, 18, 23, 25, 29, 33, 34]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [18, 33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 9, 33]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 5, 11, 14, 17, 24, 28]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 2, 13, 14, 22, 27, 30, 32]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [5, 6, 9, 10, 18, 25, 33]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [33]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [33]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GATA4\",\n      \"SRF\",\n      \"SIRT1\",\n      \"HDAC1\",\n      \"SMAD3\",\n      \"SMAD4\",\n      \"HEY1\",\n      \"GATA6\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}